Early FDG PET in Melanoma

Clinical trial NCT02716077 · TERMINATED

Trial details

NCT number: NCT02716077
Sponsor: Abramson Cancer Center at Penn Medicine
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma

Start date: 2016-03-01
Primary completion: 2021-03-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.